NCT05165433 · Interventional trial
Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)
Overall registry status Completed
Phase 1
Conditions Epithelial Tumor, Metastatic Cancer
Delaware Valley sites
- Perelman Center of Advanced Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory